Expanded Access for ATB200/AT2221 for the Treatment of Pompe Disease

NCT03865836 · clinicaltrials.gov ↗

AVAILABLE

Status

INDUSTRY

Sponsor class

Conditions

Pompe Disease

Interventions

BIOLOGICAL: ATB200
DRUG: AT2221

Sponsor

Amicus Therapeutics